Skip to main content
SpringerLink
Log in

Medical treatment of thyroid carcinoma

  • Chapter
Diagnosis and Management of Endocrine-related Tumors

Part of the book series: Cancer Treatment and Research ((CTAR,volume 20))

Abstract

Since this chapter is entitled the Medical treatment of thyroid carcinoma most of the emphasis will be on the treatment of papillary and follicular carcinoma of the thyroid with radioactive iodine, Na131I. Other thyroid malignancies will be discussed primarily as they relate to the above topic. Similarly, the diagnosis and classification of thyroid malignancies will be discussed only as they relate to medical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Third National Cancer Survey, N.C.I. Monograph 41, 1975.

    Google Scholar 

  2. Incidence, five leading cancer sites in young adult females (15–34) Ca-A. Cancer Journal for Clinicians 32: 39, Jan/Feb, 1982. (From Biometry Branch, National Cancer Institute)

    Google Scholar 

  3. Williams ED, Doniach MD, Bjorenson O, et al.: Thyroid cancer in an iodine rich area. Cancer 39: 215, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Thompson NW, Nishiyama RN, Harkness JK: Thyroid carcinoma: Current controversies. Curr Prob Surg 25: 1–17, 1978.

    Google Scholar 

  5. Beierwaltes WH, Nishiyama RN, Thompson NW, et al.: Survival time and ‘cure’ in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy. J Nucl Med 23: 561, 1982.

    PubMed  CAS  Google Scholar 

  6. Winship T and Rosvoll RW: Childhood thyroid carcinoma. Cancer 14: 734, 1961.

    Article  PubMed  CAS  Google Scholar 

  7. Rawson RW, Leeper RD: Chapter 27, Treatment of thyroid cancer with radioactive iodine. In: Nuclear Medicine, 2nd ed., Blahd WH. Blakiston: McGraw Hill Book Co., 1965, p 745.

    Google Scholar 

  8. Perzik SL: Total thyroidectomy in Graves’ disease in children. J Pediatr Surg 11: 191, 1976.

    Article  PubMed  CAS  Google Scholar 

  9. Thompson NW, Dunn EL, Freitas JE, et al.: Surgical treatment of thyrotoxicosis in children and adolescents. J Pediatr Surg 12: 1009, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Leeper RD: The effect of 131I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab 36: 1143, 1973.

    Article  PubMed  CAS  Google Scholar 

  11. Leeper RD: Controversies in the treatment of thyroid cancer: The New York Memorial Hospital approach. Thyroid Today,, July/August, 1982.

    Google Scholar 

  12. Beierwaltes WH, Johnson PC: Thyroid carcinoma treated with radioactive iodine. An eight-year experience. J Mich State Med Soc 55: 410, 1956.

    PubMed  CAS  Google Scholar 

  13. Beierwaltes WH: The treatment of thyroid carcinoma with radioactive iodine. Sem Nucl Med 8: 79–94, 1978.

    Article  CAS  Google Scholar 

  14. Sawyer VL, Block MD, Bowman HE: Results of surgical management of carcinoma of the thyroid. J Mich State Med Soc 56: 468, 1957.

    PubMed  CAS  Google Scholar 

  15. Block MD: Well differentiated carcinomas of the thyroid. In: Current Problems in Cancer. Vol 3, 1979, Year Book Med Publ Inc, 1979, pp 1–60.

    Google Scholar 

  16. Mazzaferri EL, Young RL, Oertel JE, et al.: Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 56: 171, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Mazzaferri EL: Papillary thyroid carcinoma: A10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70: 511, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Maheshuari YK, Hill CS, Jr., Haynie TP, et al.: 131I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience. Cancer 47: 664, 1981.

    Article  Google Scholar 

  19. Bestagno MF, Pagliaini R, Mavra G, Terzi A: The Use of radioiodine in the management of the differentiated thyroid cancer. Radioanalytical Chemistry 65: 239, 1981.

    Article  Google Scholar 

  20. McCowen KD, Adler RA, Ehaed N, et al.: Low dose radioiodine thyroid ablation in post surgical patients with thyroid cancer. Am J Med 61: 52, 1976.

    Article  PubMed  CAS  Google Scholar 

  21. Kuni CC, Klingensmith WC: Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer. Radiol 137: 773, 1980.

    CAS  Google Scholar 

  22. Siddigarri AR, Edmanson J, Wellman HH, et al.: Feasibility of low doses of 131I for thyroid ablation in post surgical patients with thyroid carcinoma. Clin Nucl Med 6: 158, 1981.

    Article  Google Scholar 

  23. Chabner BA: Second neoplasm—A complication of cancer chemotherapy. N Engl J Med 297: 213, 1977.

    Article  PubMed  CAS  Google Scholar 

  24. Beierwaltes WH, Copp JE: Relationship of millicure dose of 131I for ablation of thyroid remnants to results in patients with well-differentiated thyroid carcinoma. (In preparation).

    Google Scholar 

  25. Freedburg AS, Kurland GA, Blumgart HL: The pathologic effects of 1–131 on the normal thyroid gland of man. J Clin Endocr 12: 1315, 1952.

    Article  Google Scholar 

  26. Varma VM, Beierwaltes WH, Nofal MH, Nishiyama RH and Copp J: Treatment of thyroid cancer: Death rates after surgery, and after surgery followed by 131I. JAMA 214: 1437–1442, 1970.

    Article  PubMed  CAS  Google Scholar 

  27. Benua RS, Cicale NR, Sonenberg M, et al.: The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgen 87: 171, 1962.

    PubMed  CAS  Google Scholar 

  28. Phillips AF: The gamma ray dose in carcinoma of the thyroid treated by radioiodine. Acta Radiol 41: 533, 1954.

    Article  PubMed  CAS  Google Scholar 

  29. Harness JK, Thompson NW, Sisson JC, et al.: Differentiated thyroid carcinomas: Treatment of distant metastases. Arch of Surg 108: 410, 1974.

    CAS  Google Scholar 

  30. Beierwaltes WH: New horizons for therapeutic Nuclear Medicine in 1981. J Nucl Med 22: 549, 1981.

    PubMed  CAS  Google Scholar 

  31. Sisson JC, Beierwaltes WH: The effect of thyroidectomy with and without thyroxine replacement on transplantable thyroid tumors in rats. Endocrinology 74: 925–929, 1964.

    Article  PubMed  CAS  Google Scholar 

  32. Kumar MS, Chiang T, Deodhar SD: Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems. Cancer Res 39: 3515, 1979.

    PubMed  CAS  Google Scholar 

  33. Vonderhaar BK, Greco AE: Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer Res 42: 4553, 1982.

    PubMed  CAS  Google Scholar 

  34. Krishnamurthy GT, Blobd WH: Human reactions to bovine TSH. J Nucl Med 18: 629, 1977. (abstract).

    Google Scholar 

  35. Hays MT, Solomon DH, Beall GN: Suppression of human thyroid function by antibodies to bovine thyrotropin. J Clin Endocrinol Metab 27: 1540, 1967.

    Article  PubMed  CAS  Google Scholar 

  36. Hershman JM, Edwards CL: Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: Implications for 131I treatment of thyroid carcinoma. J Clin Endocrinol Metab 34: 814, 1972.

    Article  PubMed  CAS  Google Scholar 

  37. Gershengorn MC, Weintraub BD, Robbins J: Response to oral thyrotropin releasing hormone in athyreotic patients with thyroid cancer. In: Proceedings of 7th International Thyroid Conference, Boston 1975, Robbins J, Braverman LE (eds). In: Excerpta Medica International Congress Series #378, 1975, p 575.

    Google Scholar 

  38. Goldman JM, Line BR, Aamodt RL, Robbins J: Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer. J Clin Endocrinol Metab 50: 734, 1980.

    Article  PubMed  CAS  Google Scholar 

  39. Singer PA, Nicoloff JF, Stein RB, Joravillo J: Transient TRH deficiency after prolonged thyroid hormone therapy. J Clin Endocrinol Metab 47: 512, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. Krugman LG, Hershman JM, Chapra IV, et al.: Patterns of recovery of the hypothalmic-pituitary thyroid axis in patients taken off chronic thyroid therapy. J Clin Endocrinol Metab 41: 70, 1975.

    Article  PubMed  CAS  Google Scholar 

  41. Fukuchi M, Tachibana K, Kuuata K, Nishikawa A, et al.: Thallium-201 imaging in thyroid carcinoma — appearance of a lymph node metastasis. J Nucl Med 19: 195–196, 1978.

    PubMed  CAS  Google Scholar 

  42. Haroda T, Ito Y, Shimaoka K, Tanigachi T, Watsudo A, Senoo T: Clinical evaluation of 201 Thallium Chloride scan for thyroid nodule. Eur J Nucl Med 5: 125–130, 1980.

    Article  Google Scholar 

  43. Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri: Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 3: 283, 1980.

    Google Scholar 

  44. Schneider AB, Line BR, Goldman JM, Robbins J: Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab 53: 1199, 1981.

    Article  PubMed  CAS  Google Scholar 

  45. Echenique RL, Kasi L, Haynie TP, Glenn HJ, Samaan NA, Hill CS: Critical evaluation of serum thyroglobulin levels and 1–131 scans in post-therapy patients with differentiated thyroid carcinoma: Concise communication. J Nucl Med 23: 235, 1982.

    PubMed  CAS  Google Scholar 

  46. Rawson RW, Rail JE, Peacock W: Limitations and indications in treatment of cancer of thyroid with radioactive iodine. J Clin Endocrinol 11:1128, 1951.

    Article  CAS  Google Scholar 

  47. Henk JM, Hirtsman S, Own CM: Whole body scanning and 131I therapy in the management of thyroid carcinoma. Br J Radiol 45: 369, 1972.

    Article  PubMed  CAS  Google Scholar 

  48. Cady B: Risk factor analysis in differrentiated thyroid cancer. Ann Surg 18: 541, 1976.

    Article  Google Scholar 

  49. Carr EA, Jr., Dingledine WS, Beierwaltes WH: Premature resort to X-ray therapy. A common error in treatment of carcinoma of the thyroid gland. Lancet 78: 478–483, 1958.

    Google Scholar 

  50. Haynie TP, Beierwaltes WH: Hematologic changes observed following 1–131 therapy for thyroid carcinoma. J Nucl Med 4: 85–91, 1963.

    PubMed  CAS  Google Scholar 

  51. Halron KE: The non-surgical treatment of thyroid cancer. Br J Surg 62: 769, 1975.

    Article  Google Scholar 

  52. Pochin EE: The occurrence of leukemia following radioiodine therapy. In: Advances in Thyroid Research, Pitt-Dinen. New York: Pergammon Press, p 392.

    Google Scholar 

  53. Brinckner H, Hanren HR, Anderson AP: Induction of leukemia by 131I treatment of thyroid carcinoma. Br J Cancer 28: 232, 1973.

    Article  Google Scholar 

  54. Rubin P, Landman S, Mayer E: Bone marrow regeneration and extension after extended field irradiation in Hodgkin’s disease. Cancer 32: 699, 1973.

    Article  PubMed  CAS  Google Scholar 

  55. Knorpe WH, Royudu LMS, Cartello M: Bone marrow scanning with 52 Iron (52Fe) regeneration and extension after ablative doses or radiotherapy. Cancer 37: 1432, 1976.

    Article  Google Scholar 

  56. Hellman DE, Kartchner M, VanAntwerp JD, Salmon SE, Patton DD, O’Mara R: Radioiodine in the treatment of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 48: 451, 1979.

    Article  PubMed  CAS  Google Scholar 

  57. Deftos LJ, Stein MF: Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma: J Clin Endocrinol Metab 50: 967, 1980.

    Article  PubMed  CAS  Google Scholar 

  58. Porthasarathy KL, Shimaoks K, Bokski SP, et al.: Radiotracer uptake in medullary carcinoma of the thyroid. Clin Nucl Med 5: 45, 1980.

    Article  Google Scholar 

  59. Nusynowitz ML, Pollard E, Benedetto AR, Lecklitner ML, Ware RW: Treatment of medullary carcinoma of the thyroid with 131I. J Nucl Med 23: 143, 1982.

    PubMed  CAS  Google Scholar 

  60. Thereston V, Williams ED: The effect of radiation on thyroid C-cells. Acta Endocrinol 99: 72, 1982.

    Google Scholar 

  61. Rail JE, Alpers JB, LeWallen CG: Radiation pneumonitis and fibrosis: A complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J Clin Endocrinol 17: 1263, 1967.

    Google Scholar 

  62. Sarker SD, Beierwaltes WH, Gill SP, et al.: Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med 17: 460–464, 1976.

    Google Scholar 

  63. Thomas SR, Maxon NR, Keriakes JG, et al.: Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer. Radiology 122: 731, 1977.

    PubMed  CAS  Google Scholar 

  64. Koral KF, Adler RS, Carey JE, Kline RC, Beierwaltes WH: Two-orthogonal-view method for quantification of rad dose to neck lesions in thyroid-cancer-therapy patients. Medical Physics 9(4): 497–505, 1982.

    Article  PubMed  CAS  Google Scholar 

  65. Evans RC: Radium poisoning: II. The quantitative determination of the radium contect and radium elimination rate in living persons. Am J Roetgenol 32: 368, 1937.

    Google Scholar 

  66. Scott JS, Halran KE, Shimmins V, et al.: Measurement of dose to thyroid carcinoma metastases from radioiodine therapy. Br J Radiol 43: 256, 1970.

    Article  PubMed  CAS  Google Scholar 

  67. Block MA, Mitter JM, Horn RC, Jr.: Thyroid carcinoma with cervical lymph node metastasis. Effectiveness of total thyroidectomy and node dissection. Am J Surg 122: 458, 1971.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. William H. Beierwaltes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, The Milton S. Hershey Medical Center, The Pennsylvania State University, 17033, P.O. Box 850, Hershey, PA, USA

    Richard J. Santen M.D. (Professor of Medicine, Chief) & Andrea Manni M.D. (Associate Professor of Medicine) (Professor of Medicine, Chief) &  (Associate Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Beierwaltes, W.H. (1984). Medical treatment of thyroid carcinoma. In: Santen, R.J., Manni, A. (eds) Diagnosis and Management of Endocrine-related Tumors. Cancer Treatment and Research, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2849-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2849-0_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9798-7

  • Online ISBN: 978-1-4613-2849-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation